Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
S-Nitrosylation: An Emerging Paradigm of Redox Signaling.
Fernando V, Zheng X, Walia Y, Sharma V, Letson J, Furuta S. Fernando V, et al. Antioxidants (Basel). 2019 Sep 17;8(9):404. doi: 10.3390/antiox8090404. Antioxidants (Basel). 2019. PMID: 31533268 Free PMC article. Review.
S-Nitrosylation in Tumor Microenvironment.
Sharma V, Fernando V, Letson J, Walia Y, Zheng X, Fackelman D, Furuta S. Sharma V, et al. Among authors: fernando v. Int J Mol Sci. 2021 Apr 27;22(9):4600. doi: 10.3390/ijms22094600. Int J Mol Sci. 2021. PMID: 33925645 Free PMC article. Review.
Major sources of sinking particulate organic matter in the western Bay of Bengal.
Krishna MS, Lenka S, Sridevi B, Rao NS, Rao DN, Sarma VVSS, Mithun GG, Prakash TA, Khalap ST, Satelkar NP, Siddharth G, Fernando V. Krishna MS, et al. Among authors: fernando v. Mar Environ Res. 2024 May;197:106480. doi: 10.1016/j.marenvres.2024.106480. Epub 2024 Mar 30. Mar Environ Res. 2024. PMID: 38564848
Neutrophil extracellular trap formation linked to idiopathic pulmonary fibrosis severity and survival.
Matson SM, Ngo LT, Sugawara Y, Fernando V, Lugo C, Azeem I, Harrison A, Alsup A, Nissen E, Koestler D, Washburn MP, Rekowski MJ, Wolters PJ, Lee JS, Solomon JJ, Demoruelle MK. Matson SM, et al. Among authors: fernando v. medRxiv [Preprint]. 2024 Jan 25:2024.01.24.24301742. doi: 10.1101/2024.01.24.24301742. medRxiv. 2024. PMID: 38343853 Free PMC article. Preprint.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
27 results